Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$55.13 -0.30 (-0.54%)
2/9/2010 4:03 PM

Covance, Inc. (CVD)

CAPS Rating:
****

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating CVD

Add Stock to Watchlist

What the Community Thinks

Total Members

350 Outperforms
8 Underperforms
 

All-Stars

134 Outperforms
2 Underperforms
 

Wall Street

11 Outperforms
0 Underperforms
 

Members bullish on CVD are also bullish on:

Members bearish on CVD are also bearish on:

Ticker Tags

Mid Cap (610), Growth (1902), Life Sciences Tools and Services (53), Contract Research Services (7), Defensive (1457), Healthcare (711)
Suggest a tag

Covance, Inc. At A Glance

Current Price: $55.13
Last Trade Time: 2/9/2010 4:03 PM
Open: $55.82
Previous Close: $55.43
Daily Range: $54.63 - $56.62
52-Week Range: $32.31 - $61.59
Volume: 925,614
Market Cap: $3.53B
P/E Ratio: 21.16
Compare Our Special Broker Offers!

Stock Trends

CVD VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Covance, Inc. (CVD)

Avatar 97E3LPL (90.81) Submitted: 12/16/08 9:12 AM

Pharma is among the least affected industries, however they are seeking cost reductions, effiiciency gains, etc like everyone else. The usual and likely avenue for that is CROs, and if you read the news for this company, they are already reeping rewards.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

2

Covance, Inc. (CVD)

Avatar epumple (< 20) Submitted: 6/26/08 2:44 PM

Covance is notorious for its cruel treatment of its laboratory animals and is the subject
of a major campaign by Peta. Unlike most industries that use animals, Covance has
been totally resistant to negotiation on this issue. I believe this is a sign of un...More

Replies: 5 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 46 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (CVD)

Avatar TMFQue (98.06) Submitted: 2/01/10 11:42 AM : Outperform Start Price: $56.83 CVD Score: -1.70

Stocks 360

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CVD)

Avatar 00100 (96.16) Submitted: 1/28/10 2:41 PM : Outperform Start Price: $58.99 CVD Score: -5.18

Upthumb. Low risk cash cow. No debt.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CVD)

Avatar BLAYNE100 (96.43) Submitted: 11/16/09 8:46 PM : Outperform Start Price: $53.76 CVD Score: 5.88

Strong Sector for 2010

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CVD)

Avatar mrmok (72.90) Submitted: 11/16/09 1:53 AM : Outperform Start Price: $53.70 CVD Score: 5.53

FC

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CVD)

Avatar wooderino (96.95) Submitted: 10/27/09 12:35 PM : Outperform Start Price: $54.69 CVD Score: 0.44

Showed up on a screen for solid 5 year growth with low debt, cash on hand and still at attractive P/E ratios.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 46 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 11 of 11  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJefferies 82.08 09/23/09 Outperform NS $56.80-2.94%+0.13%-3.07
TrackJPMorgan 84.76 07/16/09 Outperform NS $47.41+16.28%+15.83%+0.46
TrackDeutscheSec 89.68 05/13/09 Outperform NS $39.09+41.03%+20.73%+20.30
TrackPiperJaff 85.79 12/23/08 Outperform NS $41.73+32.11%+24.67%+7.45
TrackEdwardJones 83.68 11/17/08 Outperform NS $39.05+41.18%+27.51%+13.67
TrackUBS 87.99 02/04/08 Outperform NS $82.95-33.54%-19.73%-13.81
TrackWellsFargo 80.02 11/28/07 Outperform NS $85.47-35.50%-22.09%-13.41
TrackRonBaron 59.71 09/30/07 Outperform NS $77.90-29.23%-26.38%-2.85 Toggle the visibility of 60-Second Pitch and replies
TrackBofASec 94.61 06/28/07 Outperform NS $69.52-20.70%-25.01%+4.31
TrackLehmanBros 85.06 05/08/07 Outperform NS $65.75-16.15%-24.56%+8.41
TrackJimCramer < 20 01/19/07 Outperform 3W $62.03-11.12%-20.32%+9.19

Results 1 - 11 of 11  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 375ms